isolated and combined use of bisphosphonates, statins and flavonoids in osteoporotic female rat
Clicks: 239
ID: 182824
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
239 views
40 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #10 of 25 articles by views in 4th ccps global summit on process safety 2017
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
ABSTRACT. Amaral G.G., Del Carlo R.J., Oliveira T.T., Louzada M.J.Q., Valadares R.F.D., Ribeiro M.D. & Pinto A.S. [Isolated and combined use of bisphosphonates, statins and flavonoids in osteoporotic female rat.] Uso isolado e combinado de bisfosfonatos, estatina e flavonóide em ratas osteoporóticas. Revista Brasileira de Medicina Veterinária, 36(1):105-110, 2014. Programa de Pós- -Graduação em Ciências Veterinárias, Departamento de Veterinária, Universidade Federal de Viçosa, Av. Peter Henry Rolfs, S/N, Viçosa, MG 36571-000, Brasil. E-mail: aloisio@ufv.br This study aimed to treat osteoporosis induced by ovariectomy through the single and combined use, by employing, in this case, half of the defined doses of the isolated compounds etidronate, risedronate (bisphosphonates), pravastatin (statin) and ipriflavone (flavonoid).The experiment consisted of 66 rats were divided into 11 groups of 6 animals, taking control and osteoporosis, the most isolated groups etidronate, risedronate, pravastatin and ipriflavone and associated etidronate + pravastatin, etidronate + ipriflavone, risedronate + pravastatin, risedronate + ipriflavone and pravastatin + ipriflavone. After 12 weeks of ovariectomy, began administering the drug orally for 30 days. After 35 days, the animals were sacrificed and blood was collected for biochemical analysis and the tibias for analysis bone mineral density.The value of the biochemical markers calcium, phosphorus, albumin, total protein and bone alkaline phosphatase presented no statistically significant differences. These results provide no information for the diagnosis and monitoring of osteoporosis. Bone densitometry presented significant results for induction and for different treatments, in relation to the osteoporotic group. The results reveal that associations have the same pharmacological activity as isolated substances, and no antagonistic effect was observed. Thus, associations can be a therapeutic alternative, since possible side effects can be reduced by the administration of half the individual dose prescribed.
| Reference Key |
amaral2014brazilianisolated
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Gláucia Guimarães Amaral;Ricardo Junqueira Del Carlo;Tânia Toledo de Oliveira;Mário Jefferson Quirino Louzada;Rilene Ferreira Diniz Valadares;Mariella Dias Ribeiro;Aloísio da Silva Pinto |
| Journal | 4th ccps global summit on process safety 2017 |
| Year | 2014 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.